Ipratropium bromide 0.5 mg/3 mL (0.017%), albuterol (as sulfate) 2.5 mg/3 mL (0.083%); soln for inh. Not for primary treatment of acute attack. Avoid excessive use. Discontinue if paradoxical ...

Objectives Continuous albuterol nebulization is generally administered at 2.5–20 mg/hr at most centers. We examined the effect of high-dose (75 or 150 mg/hr) albuterol on clinical variables in ...

After years of limited advancements in chronic obstructive pulmonary disease (COPD) treatment, patients now have new options.

Ipratropium bromide 0.06% (42mcg/spray); aqueous soln. Ipratropium bromide, an anticholinergic (parasympatholytic) agent, has antisecretory properties which inhibit secretions from the serous and ...

Overall, cilomilast is well tolerated, with 4 clinical trials encompassing 1151 patients reporting the most common adverse effects to be diarrhea, nausea, dizziness, and headaches. [10,11,12,13 ...

In accordance with the latest Enforcement Report from the US Food and Drug Administration (USFDA), Cipla's subsidiary in New Jersey is recalling 59,244 packs of Ipratropium Bromide and Albuterol ...

Allergens are substances that cause an immune response ranging from a runny nose to shortness of breath. Allergic reactions ...

A tapering course of prednisone and inhaled albuterol were prescribed ... furosemide and piperacillin–tazobactam and inhaled ipratropium were administered. Diagnostic tests were performed ...

Bronchodilators to open the airways (e.g., albuterol or ipratropium bromide and albuterol) Untreated anaphylaxis can lead to hypotension (low blood pressure), incontinence, fainting, shock ...

Not currently distributed in Australia. Each 1 mL of Atrovent Adult UDV contains 522 micrograms of ipratropium bromide monohydrate (equivalent to 500 micrograms of ipratropium bromide) as the ...

Atrovent Inhalation Solution contains the active ingredient ipratropium bromide monohydrate. It belongs to a group of medicines called anticholinergic bronchodilators. Atrovent Inhalation Solution ...